Drugs / DDP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02907710 Background | Oct 2016 → Nov 2018 | nasopharyngeal carcinoma | First Affiliated Hospital of Guangxi Medical University | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02907710 ↗ |
| Route | Intravenous | “DDP 100mg / m2, intravenous infusion over 2 hours” NCT02907710 ↗ |